Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT07312578
What this trial is testing

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 48
Testing effectiveness (Phase 2)Ended earlyNCT01230476
What this trial is testing

Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
University of Malaya 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884
What this trial is testing

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Who this might be right for
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more
Haihua Yuan 15
Testing effectiveness (Phase 2)Looking for participantsNCT07162506
What this trial is testing

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)UnknownNCT01993784
What this trial is testing

Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Cancer
Peking University 9
Testing effectiveness (Phase 2)Looking for participantsNCT07061704
What this trial is testing

Oncolytic Virus in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Sichuan University 40
Not applicableStudy completedNCT01075828
What this trial is testing

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea

Who this might be right for
Head and Neck Cancer
Merck KGaA, Darmstadt, Germany 221
Testing effectiveness (Phase 2)Study completedNCT03409848
What this trial is testing

Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma

Who this might be right for
Gastric CancerEsophageal CancerAdenocarcinoma Gastric+3 more
AIO-Studien-gGmbH 97
Testing effectiveness (Phase 2)Ended earlyNCT02291055
What this trial is testing

ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer

Who this might be right for
Cervical CancerCancerHead and Neck Cancer
Advaxis, Inc. 75
Testing effectiveness (Phase 2)Looking for participantsNCT07362979
What this trial is testing

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 243
Early research (Phase 1)Study completedNCT00513383
What this trial is testing

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Massachusetts General Hospital 34
Early research (Phase 1)Ended earlyNCT03558724
What this trial is testing

Fluorescence Endoscopy of Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
University Medical Center Groningen 25
Testing effectiveness (Phase 2)UnknownNCT05898373
What this trial is testing

Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC

Who this might be right for
Salivary Gland Cancer
Peking Union Medical College 120
Large-scale testing (Phase 3)Ended earlyNCT02952586
What this trial is testing

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Pfizer 697
Not applicableStudy completedNCT05292027
What this trial is testing

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 84
Testing effectiveness (Phase 2)Study completedNCT00468169
What this trial is testing

Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Chicago 110
Early research (Phase 1)Ended earlyNCT00882583
What this trial is testing

Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Testing effectiveness (Phase 2)Looking for participantsNCT07435454
What this trial is testing

Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Jiangsu Cancer Institute & Hospital 22
Not applicableLooking for participantsNCT02972372
What this trial is testing

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophagus Cancer
The First Affiliated Hospital of Henan University of Science and Technology 196
Testing effectiveness (Phase 2)Looking for participantsNCT06869213
What this trial is testing

A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma

Who this might be right for
Esophageal Cancer (EsC)
Peking University Cancer Hospital & Institute 30
Next Page